Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Lipid metabolism, disorders

One class of glycogen or lipid metabolic disorders in muscle is manifest as acute, recurrent, reversible dysfunction 696... [Pg.695]

These effects are reversible after cessation of therapy. Patients who are at high risk of developing hypertriglyceridemia include those with diabetes, obesity, increased alcohol intake, a lipid metabolism disorder, and a familial history. [Pg.2036]

Diarylcycloalkyl derivatives, (V), prepared by the author (6) in earlier investigations were effective as lipid- and/or triglyceride-lowering chemical agents used in treating lipid metabolism disorders. [Pg.272]

Schimming W, Schentke K, Gehrich S, Jaross W, Kobe E (1991) Lipid metabolism disorders in primary biliary cirrhosis (PBC). Gastroenterol / 51 18-21. [Pg.254]

TNF is a pleiotropic cytokine exerting a wide range of cellular responses, that affect biological processes such as lipid metabolism, coagulation, and insulin resistance and the function of endothelial cells. As a major proinflammatory cytokine TNF is also involved in progression of diseases like cancer, Alzheimer, Diabetes type II, cardiovascular, pulmonary or neurological disorders, and many autoimmune diseases. Blocking the action of TNF clearly reduces its inflammatory potential on various autoimmune disorders like Crohn s disease, rheumatoid arthritis (RA), and psoriasis. [Pg.1249]

Metabolic Myopathies Glycogen Storage Disease Disorders of Lipid Metabolism Respiratory Chain Disorders Mitochondrial DNA Abnormalities Myotonias, Periodic Paralyses, and Malignant Hyperpyrexia Myotonias... [Pg.281]

DiDonato, S., Taroni, F. Disorders of lipid metabolism. In R. N. Rosenberg, S. B. Prusiner, S. DiMauro, R. L. Barchi and E. J. Nestler (eds), The Molecular and Genetic Basis of Neurological Disease. Boston Butterworth-Heinemann, 2003, pp. 591-601. [Pg.711]

For many years, alterations in APOE and defects in the APOE gene have been associated with dysfunctions in lipid metabolism, cardiovascular disease, and atherosclerosis. During the past 25 years, an enormous amount of studies clearly documented the role of APOE-4 as a risk factor for AD, and the accumulation of the APOE-4 allele has been reported as a risk factor for other forms of dementia and CNS disorders (1,12,18-20,47.488). [Pg.297]

Cardiovascular and cerebrovascular disorders associated with lipid metabolism disturbance and atherosclerosis represent major risk factors for dementia (3,25,59). Atherosclerosis is the primary cause of heart disease and stroke in which genetic and environmental factors converge (553). More than 90% of patients older than 70-80 yr with dementia show signs of atherosclerosis in their arteries and a clear cerebrovascular component in their dementia process. It is very likely that pure AD is practically absent in octogenarians, in whom the prevalent diagnosis is vascular or mixed dementia (3,25,59), in which the APOE-4 allele also accumulates (18-20,554). [Pg.308]

Diabetes mellitus is a heterogeneous group of disorders characterized by abnormalities in carbohydrate, protein, and lipid metabolism. The central disturbance in diabetes mellitus is an abnormality in insulin production or action or both, although other factors can be involved. Hyperglycemia is a common end point for all types of diabetes mellitus and is the parameter that is measured to evaluate and manage the efficacy of diabetes therapy. [Pg.767]

Disorder of protein metabolism could be noticed in 13% decrease of total protein content in blood serum. The observed hypoproteinemia was stipulated by 25% decrease of albumin fraction. The index showing correlation between the level of middle molecules and total protein was 65% higher in Group 2 indicating prevalence of protein degradation processes over their synthesis. The revealed disorders indicated the development of liver failure syndrome. Profound disorders were also registered in lipid metabolism. We determined the intensification of lipolysis by increase in the concentration of the main lipid fractions in blood serum. The level... [Pg.226]

Plasma lipids are transported in complexes called lipoproteins. Metabolic disorders that involve elevations in any lipoprotein species are termed hyperlipoproteinemias or hyperlipidemias. Hyperlipemia denotes increased levels of triglycerides. [Pg.776]


See other pages where Lipid metabolism, disorders is mentioned: [Pg.696]    [Pg.181]    [Pg.295]    [Pg.383]    [Pg.715]    [Pg.730]    [Pg.543]    [Pg.1109]    [Pg.1042]    [Pg.3815]    [Pg.964]    [Pg.160]    [Pg.696]    [Pg.181]    [Pg.295]    [Pg.383]    [Pg.715]    [Pg.730]    [Pg.543]    [Pg.1109]    [Pg.1042]    [Pg.3815]    [Pg.964]    [Pg.160]    [Pg.495]    [Pg.1158]    [Pg.296]    [Pg.303]    [Pg.303]    [Pg.307]    [Pg.59]    [Pg.267]    [Pg.90]    [Pg.96]    [Pg.481]    [Pg.699]    [Pg.70]    [Pg.90]    [Pg.43]    [Pg.77]    [Pg.66]    [Pg.2]    [Pg.47]    [Pg.299]    [Pg.130]    [Pg.144]    [Pg.768]   
See also in sourсe #XX -- [ Pg.303 , Pg.304 , Pg.305 , Pg.306 ]

See also in sourсe #XX -- [ Pg.104 ]




SEARCH



Lipid disorders

Lipides metabolism

Lipids metabolism

Metabolic disorder

Metabolism disorders

© 2024 chempedia.info